Announcement regarding Affitech A/S Annual General Meeting 2011
28-02-11 kl. 28/2 2011 09:51 | Affitech 0,05 (-44,44%)
Se flere nyheder om Affitech
Announcement no 2, 2011
Copenhagen and Oslo, 28th February 2010, 2011-02-28 10:51 CET (GLOBE NEWSWIRE)
--
Affitech A/S (NASDAQ OMX: AFFI) today announced to its shareholders that the
deadline for proposals for the Annual General Meeting, which takes place on
28th April, 2011, is Thursday 17th March, 2011.
About Affitech
Affitech AS is a publicly traded (NASDAQ OMX Copenhagen) human therapeutic
antibody company based in Copenhagen, Denmark with R&D facilities in Oslo,
Norway. The company utilizes a range of proprietary antibody technologies for
the discovery of fully human antibodies for application in oncology,
inflammation and other disease areas. CBAS™ (Cell Based Antibody Selection) is
Affitech's premier discovery engine for the isolation of lead antibodies to
cell surface molecules in situ. Several of the Company's proprietary product
candidates were generated by CBAS™. Further information is available at
www.affitech.com.
For more information please contact
Randi Krogsgaard, Director IR & Communications
Tel # +45 2320 1001, e-mail: [email protected]
Skriv en kommentarer til denne artikel:
Send kommentar
| PRIS | 0,05 |
|---|---|
| ÆNDRING | -0,04 (-44,44%) |
| ÅBEN | 0,08 |
| SIDSTE LUK | 0,09 |
| DEBAT | - |
 |
